A critical history of individual and collective ethics in the lineage of Lellouch and Schwartz

Clinical Trials

Volumn 2, Issue 3, 2005, Pages 244-253

  Heilig, Charles M ^a   Weijer, Charles ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSTATISTICS; COLLECTIVE ETHICS; CONCEPT FORMATION; ETHICS; HISTORY; INDIVIDUAL ETHICS; INFORMATION PROCESSING; LITERATURE; MORALITY; PRIORITY JOURNAL; REVIEW; STANDARD;

BIOETHICS; CLINICAL TRIALS; ETHICAL ANALYSIS; ETHICS; ETHICS, RESEARCH; HISTORY, 20TH CENTURY; HUMANS;

EID: 21344459830     PISSN: 17407745     EISSN: None     Source Type: Journal    
DOI: 10.1191/1740774505cn084oa     Document Type: Review

References (51)

1. Lellouch J, Schwartz D. L'essai thérapeutique: éthique individuelle ou éthique collective? [The clinical trial: individual ethics or collective ethics?] Revue de l'Institut International de Statistique 1971; 39: 127-36.
2. Colton T. A model for selecting one of two medical treatments. Journal of the American Statistical Association 1963; 58: 388-400.
3. Anscombe FJ. Sequential medical trials. Journal of the American Statistical Association 1963; 58: 365-83.
4. Cornfield J, Halperin M, Greenhouse SW. An adaptive procedure for sequential clinical trials. Journal of the American Statistical Association 1969; 64: 759-70.
5. Canner PL. Selecting one of two treatments when the responses are dichotomous. Journal of the American Statistical Association 1970; 65: 293-306.
6. Hill AB. Medical ethics and controlled trials. British Medical Journal 1963; 1: 1043-49.
7. Armitage P. Sequential Medical Trials. Springfield, IL: Charles C. Thomas, 1960.
8. Armitage P. Sequential medical trials: some comments on F. J. Anscombe's paper. Journal of the American Statistical Association 1963; 58: 384-87.
9. Zelen M. Play the winner rule and the controlled clinical trial. Journal of the American Statistical Association 1969; 64: 131-46.
10. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. Journal of Chronic Diseases 1967; 20: 637-48.
11. Schwartz D, Flamant R, Lellouch J. L'essai thérapeutique chez l'homme. Paris: Flammarion médecine-sciences, 1970.
12. Schwartz D, Flamant R, Lellouch J. Clinical trials. New York: Academic Press, 1980.
13. Sancho H, Hayat M. Are controlled clinical trials unnecessary? Biomedicine 1973; 18: 173-76.
14. Weinstein MC. Allocation of subjects in medical experiments. New England Journal of Medicine 1974; 291: 1278-85.
15. Burkhardt R, Kienle G. Controlled clinical trials and medical ethics. Lancet 1978; 1604: 1356-59.
16. Burkhardt R, Kienle G. Controlled clinical trials and the importance of medical judgment. In Tagnon HJ, Staquet MJ eds. Controversies in cancer: design of trials and treatment. New York: Masson Publishing USA, 1979: 31-35.
17. World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Adopted 18th WMA General Assembly, Helsinki, Finland, June 1964; amended 29th WMA General Assembly, Tokyo, Japan, October 1975; 35th WMA General Assembly, Venice, Italy, October 1983; 41st WMA General Assembly, Hong Kong, September 1989; 48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996; and 52nd WMA General Assembly, Edinburgh, Scotland, October 2000; Note of Clarification on Paragraph 29 added by the WMA General Assembly, Washington 2002. Note of Clarification on Paragraph 30 added by the WMA General Assembly, Tokyo 2004. Available from: http:// www.wma.net/e/policy/b3.htm (accessed 22 April 2005).
18. Tubiana M. Judgment and decision in oncology. Bulletin du Cancer 1980; 67: 369-73.
19. Armitage P. Clinical trials in the secondary prevention of myocardial infarction and stroke. Thrombosis and Haemostasis 1980; 43: 90-94.
20. Vere D. Controlled clinical trials: the current ethical debate. Journal of the Royal Society of Medicine 1981; 74: 85-88.
21. Jeanneret O, Raymond L. Aspects éthiques des etudes d'intervention [Ethical aspects of intervention studies]. Revue d'Épidémiologie et de Santé Publique 1981; 29: 269-79.
22. Nuremberg Military Tribunals. Trials of war criminals before the Nuremberg Military Tribunals under Control Council Law No. 10. Washington, DC: US Government Printing Office, 1949.
23. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Belmont report: ethical principles and guidelines for the protection of human subjects of research. Washington, DC: Department of Health, Education, and Welfare, 1979.
24. Clayton DG. Ethically optimised designs. British Journal of Clinical Pharmacology 1982; 13: 469-80.
25. Pocock SJ. Clinical trials: a practical approach. New York: John Wiley & Sons, 1983.
26. Armitage P. The search for optimality in clinical trials (discussion). International Statistical Review 1985; 53: 15-36.
27. Block MR, Schaffner KF, Coulehan JL. Ethical problems of recording physician-patient interactions in family practice settings. Journal of Family Practice 1985; 21: 467-72.
28. Schaffner KF. Ethical problems in clinical trials. Journal of Medicine and Philosophy 1986; 11: 297-315.
29. Beauchamp TL, Childress JF. Principles of biomedical ethics, 2nd edn. New York: Oxford University Press, 1983.
30. Kadane JB. Progress toward a more ethical method for clinical trials. Journal of Medicine and Philosophy 1986; 11: 385-404.
31. Pocock SJ. When to stop a clinical trial. British Medical Journal 1992; 305: 235-40.
32. Pocock SJ. Statistical and ethical issues in monitoring clinical trials. Statistics in Medicine 1993; 12: 1459-69.
33. Freedman B. Equipoise and the ethics of clinical research. New England Journal of Medicine 1987; 317: 141-45.
34. Palmer CR. Ethics and statistical methodology in clinical trials. Journal of Medical Ethics 1993; 19: 219-22.
35. Freedman B, Shapiro SH. Ethics and statistics in clinical research: towards a more comprehensive examination. Journal of Statistical Planning and Inference 1994; 42: 240.
36. Schaffner KF. Ethically optimizing clinical trials. In Kadane JB ed. Bayesian methods and ethics in a clinical trial design. New York: John Wiley & Sons, 1996: 19-63.
37. Kadane JB ed. Bayesian methods and ethics in a clinical trial design. New York: John Wiley & Sons, 1996.
38. Armitage P. Attitudes in clinical trials. Statistics in Medicine 1998; 17: 2675-83.
39. Palmer CR, Rosenberger WF. Ethics and practice: alternative designs for phase III randomized clinical trials. Controlled Clinical Trials 1999; 20: 172-86.
40. Beauchamp TL, Childress JF. Principles of biomedical ethics. 3rd edn. New York: Oxford University Press, 1989.
41. Palmer CR. Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go? Statistical Methods in Medical Research 2002; 11: 381-402.
42. Ashby D, Machin D. Stopping rules, interim analyses and data monitoring committees. British Journal of Cancer 1993; 68: 1047-50.
43. Bather JA. Randomized allocation of treatments in sequential experiments. Journal of the Royal Statistical Society Series B Methodology 1981; 43: 265-92.
44. Boissel J-P. Impact of randomized clinical trials on medical practices. Controlled Clinical Trials 1989; 10 (4 Suppl): 120S-34S.
45. Jamart J. Combining the pragmatic attitude and the play-the-winner in controlled clinical trials. Biometrical Journal 1985; 27: 199-203.
46. Löwy I. "Nothing more to be done": Palliative care versus experimental therapy in advanced cancer. Science in Context 1995; 8: 209-29.
47. Pullman D, Wang XK. Adaptive designs, informed consent, and the ethics of research. Controlled Clinical Trials 2001; 22: 203-10.
48. Senn S. Ethical considerations concerning treatment allocation in drug development trials. Statistical Methods in Medical Research 2002; 11: 403-11.
49. von Eickstedt K-W. Bewertung der vershiedenen Phasen der klinischen Prüfung [Valuation of the different phases of the clinical trial]. Münchener Medizinische Wochenschrift 1983; 125: 21-25.
50. von Eickstedt K-W. The ethical position of the attending physician in phase III of clinical investigations. International Journal of Clinical Pharmacology, Therapy and Toxicology 1983; 21: 529-34.
51. Fried C. Medical experimentation: personal integrity and social policy. Amsterdam: North-Holland Publishing Company, 1974.